Cadrenal Therapeutics, Inc. Common Stock (CVKD) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 1.37 |
| FCF Yield | -96.1% |
| Sector P/E (Healthcare) | 21.7 |
CVKD overview · CVKD earnings · CVKD KPIs · CVKD investor relations · CVKD ownership · CVKD peers · CVKD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.